Skip to main content

NAPRA seeks comments on drug schedule change for pediatric loratadine products

National Drug Scheduling Advisory Committee issues interim recommendations on drug schedule status change for loratadine products used in children two to 11 years of age. 
3/28/2023

Register for free access or login.

Canadian Healthcare Network is an independent online community for Canadian healthcare professionals in medicine and pharmacy. It is the online home of the Medical Post and Pharmacy Practice + Business.

Membership is free and allows doctors, pharmacists, nurses and many others to get the latest breaking news, updates on clinical guidelines and read (and even write) commentary from your healthcare peers.

X
This ad will auto-close in 10 seconds